News for Stemcell United Limited (SCU.AX)

Ventia Services shares are up by 1.20% after announcing it has been awarded a five-year contract with the Australian DoD. This is the fourth major contract the company has secured this year.

Biotech Starpharma has received regulatory approval for its Viraleze product to be used in Malaysia, adding the product to a wider market base that now spans 35 countries as it looks into further COVID-19 studies in the UK.

Flower seller Lynch Group has upped its earnings guidance for the full year fiscal 2023, with expectations of revenue increasing 5% on a stronger performance in sales and returning of stores.

Biotech company Mesoblast has released its Q3 financial report, saying that it cut losses after tax to US$18.6 million from US$21.3 million a year ago. Shares rose more than 4% during the group’s quarter improvement.

Dusk posts its latest trading update and now expects a decrease in its sales and profits for the remainder of the financial year.

Rise and Shine: Everything you need to know before the ASX opens

Telehealth, mental health and aged care stocks rallied on Wednesday following the Budget announcement which include billions for healthcare.

The ASX wandered to a -0.25% close today as banks and oil stocks dragged the market down, leaving Magnum Mining to win the day on +44.1%

The ASX has dipped 0.2% this morning as the US braces for CPI data, while Magnum's gone flying thanks to a huge offtake deal with Mitsubishi.

The 5 stocks set to pop as lithium bottoms, some Small Industrials bargains, and is iron ore flattering to deceive?

It's been relatively quiet ahead of tonight's Federal Budget, except for Voltaic's 188% jump on hugely promising lithium results.

At the end of a crazy week, it's the goldies out in front again, more than 3.0% better than the ASX benchmark's -1.09% fizzer.

The S&P ASX 200 has ended a three day losing streak closing up 0.37%, while Codrus Metals (ASX:CDR) reports a rare earths find.

After a heart-stopping jolt, the market was flat at lunchtime, and Codrus is leading the Small Caps race, up 40% on news of a solid TREO find.

Codrus (ASX:CDR) is the latest explorer to find clay REEs, reporting grades up to 4,764ppm TREO in maiden drilling at the Karloning project.

New studies have confirmed that medical cannabis helps relieve cancer pain, or side effects from cancer treatment.

The S&P ASX 200 gained 1.85% in April 2023, extending its YTD gain to 5.38% with mid and small caps outperforming their blue-chip peers.

Some ASX stocks to go to war with, some very bullish gold hedges, and who won the ASX in April?

After a solid +0.8% start, the ASX sagged to a 0.35% close, while Small Cappers Lincoln Minerals and Optima went flying on no news at all.